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ABSTRACT 
147 patients with preterm premature rupture of 
membranes were retrospectively studied to determine 
what clinical parameters would predict a positive 
amniotic fluid culture and to assess the usefulness 
of amniocentesis in managing patients with preterm 
PROM . 
77 patients with successful amniocentesis were 
divided into two groups: those with negative amnio¬ 
tic fluid cultures and those with positive cultures. 
Maternal temperature, WBC count, neutrophil cound, 
band count, absolute neutrophil count and uterine 
irritability on admission were not predictive of a 
positive amniotic fluid culture. Similarly, at the 
time of amniocentesis, the following parameters were 
not predictive of a positive amniotic fluid culture: 
maternal age, gestational age, temperature, WBC count, 
neutrophil and band counts, absolute neutrophil count 
and presence of contractions. Gram stain of the am¬ 
niotic fluid was 6l.9^ sensitive and 91*8# specific 
in predicting a positive culture. A positive culture 
did not correlate with increased maternal morbidity 
but correlated with considerably higher rates of RDS 
and low Apgar scores in newborns. This study under- 

scores the importance of amniocentesis as an aid in 
managing the patient with preterm PROM. 

Premature rupture of the fetal membranes (PROM) 
occurs in 2.1-12.5/^ of all pregnancies according to 
several large reported studies (1-8). (See Table 1). 
It is an event that can result in serious maternal and 
fetal complications. Difficulty in management is 
greatest in the preterm gestation, where the risk of 
infection of the amniotic cavity, a common complication 
of expectant management, must be weighed against the 
risk of prematurity, resulting from early delivery. 
Prematurity is still responsible for about half of all 
infant deaths, and 40# of these are brought about fol¬ 
lowing labor after PROM (9). The rationale for prompt 
delivery of the fetus is prevention of infection, whereas 
expectant management attempts to enhance neonatal out¬ 
come by increasing fetal viability. 
A study of the problem of PROM should include a 
discussion of the anatomy and physical properties of the 
membranes in addition to discussing the causes and ef¬ 
fects of PROM. Is infection a cause or a consequence of 
PROM? What management strategy best maximizes matu¬ 
rity without increasing the incidence of infection? 
Does PROM per se enhance pulmonary maturation and thus 
decrease the risk of neonatal Respiratory Distress Syn¬ 
drome (RDS)? How can amniocentesis aid in the management 
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of PROM? 
Anatomy of the Fetal Membranes 
The fetal membranes, the amnion and the chorion, ex¬ 
tend beyond the lateral margin of the placenta, and with 
the placenta, form the closed cavity containing the fe¬ 
tus. At term the amniotic cavity contains approximate¬ 
ly one liter of amniotic fluid. 
Microscopically, from inside out, the membranes con¬ 
sist of the amnion, the chorion, and the decidua. The 
amnion, a single layer of cuboidal or cylindrical cells 
on a basement membrane over a thin collagenous layer, con¬ 
tains occasional mesenchymal cells. The attachment to 
the next layer is very loose, and the amnion is readily 
peeled off. The zone of contact is actually a virtual 
cavity representing a remnant of the extraembryonic coe¬ 
lom. The chorion (chorion laeve - smooth chorion), a 
thicker, fibrous avascular layer, contains, like the am¬ 
nion, multipotential mesenchymal cells with both fibro¬ 
blastic and phagocytic properties. The decidua, a well- 
vascularized maternal tissue, contains occasional lym¬ 
phocytes . 
The fetal surface of the placenta is normally shiny 
with a bluish color. From the fetal surface out towards 
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the maternal surface, the following layers are encoun¬ 
tered: the amnion, the placental chorion, the villi and 
intervillous space, and the basal decidua. There are 
no polymorphonuclear cells in the normal amnion, chorion, 
or placenta (10). 
When the amnion at term is examined by transmission 
electron microscopy, pedicles can be seen extending into 
the basement membrane. The intercellular junctions are 
formed by desmosomes and a labyrinthine channel system. 
The basement membrane seems to play a primordial 
role in preserving the intact amniotic cavity, and the 
presence of pedicles is suggestive of active transport 
(11) . 
Physical Properties of the Membranes and Premature Rupture 
There has been considerable interest in the physical 
properties of membranes which rupture prematurely. The 
amnion, which is rich in collagen, is the main load- 
bearing component of the membranes (12). MacLahan (13) 
determined that the mean bursting pressure of the mem¬ 
branes was 393 mm Hg. Several studies (14) have failed 
to show differences in the physical properties of pre¬ 
maturely- versus appropriately-ruptured membranes. Skin¬ 
ner et al (12), however, found that the collagen content 
of the human amnion decreases significantly during the 
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last eight weeks of pregnancy and found that this de¬ 
crease was also observed, at an earlier gestational age, 
in pregnancies with PROM. To determine whether the rela¬ 
tive decrease in the collagen content of prematurely rup¬ 
tured membranes was a cause rather than an effect of PROM, 
the authors investigated the effect of the duration of 
ruptured membranes on their collagen content. They found 
a slight but significant increase in the collagen content 
of the amnion as the latent period between rupture and on¬ 
set of labor increased. The collagen values were norma¬ 
lized to a single gestational age to eliminate bias due 
to a possible association between long latent period and 
early PROM. Their results suggest that rupture of the 
membranes does not in itself enhance collagen degradation, 
but that weakening of the amnion in preparation for rup¬ 
ture may be determined partly by factors controlling the 
synthesis and degradation of collagen. Wideman et al (15) 
suggest that PROM may be associated with ascorbic acid 
deficiency. In their series of 288 pregnancies, 1^.6% 
of patients with ascorbic acid levels of less than 0.20 
mg^ had PROM as compared to 1.5f of patients whose plasma 
ascorbic acid levels were greater than 0.60 mgfi. Skin¬ 
ner and Liggins (16) found that the concentration of 
sulphated glycosaminoglycans decreased significantly 
near term, and again found a statistically significant 
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earlier decrease in pregnancies with PROM. Unfortu¬ 
nately, the relative contribution of these factors in 
individual cases of PROM has not been determined. Studies 
of the physical properties of the membranes have been 
criticized (17) because of differences in measuring 
techniques, possible deterioration of membrane prepa¬ 
rations, and inherent difficulties with establishing 
adequate controls. 
Etiology of PROM 
The etiology of PROM has not been yet determined. 
Some ruptures have a clear-cut cause, such as an incom¬ 
petent cervix, polyhydramnios or trauma (18), but in some 
cases there is no explanation. Other predisposing factors 
which have been proposed include cervicitis, amnionitis, 
placenta previa, genetic abnormalities of the fetus, 
fetal malpresentations, increased intrauterine pressure 
due to multiple gestation, previously induced abortion, 
abruption, coitus, and vaginal infections (14), as well 
as the intrinsic abnormalities of the membranes discus¬ 
sed in the previous section. Naeye and Peters (18) 
studied 6613 pregnancies that ended before term to deter¬ 
mine whether amniotic fluid infections could be a cause 
as well as a complication of PROM. They found that on 
pathological examination, amniotic fluid infections 
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were two to three times more common when the fetal mem¬ 
branes ruptured just before labor started than when 
they ruptured just after the onset of labor. They also 
found that although coitus in the preceeding month did 
not increase the chance of PROM it increased the his¬ 
tological severity of the infections associated with 
PROM. Parity did not increase the chance of PROM but 
again the infections in multiparas were pathologically 
more severe than in primiparas. The possibility that 
amniotic fluid infection may be a cause of PROM had 
been suggested in 1972 by Cederqvist (19) who found that 
63/? of cord bloods in infants born after PROM had in¬ 
creased levels of IgM or IgA, suggesting that these 
fetuses had experienced infections of some duration. 
There thus seem to be two distinct sets of patients 
who rupture their membranes prematurely: those who are 
not infected at the time of PROM and who may remain un¬ 
infected for several weeks, and those whose premature 
rupture seems to have been caused by a preexisting am¬ 
niotic fluid infection. 
In a study of 10,640 pregnancies, Naeye (20) found 
that the recurrence risk of PROM in the next pregnancy 
was 21%. He found an incidence of only 4% in pregnancies 
which followed a normal pregnancy. Preterm PROM increased 
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significantly with parity, but only after the third 
pregnancy. 
Latent Period Between PROM and Delivery 
With increasing time interval between PROM and 
delivery, the risk of developing intrauterine infec¬ 
tion becomes greater (9)* The term fetus does not suf¬ 
fer significantly in most cases, since over 80% of 
patients with PROM at term will go into spontaneous 
labor before 24 hours. Presently, induction with oxy¬ 
tocin is almost standard procedure for term patients 
with PROM who are not in labor after 12 to 24 hours 
after rupturing membranes. 
About 35-50% of patients with PROM before 36 weeks 
gestational age will go into spontaneous labor within 
24 hours (9)* All authors agree that there is an in¬ 
verse relationship between length of gestation and la¬ 
tent period between rupture of membranes and delivery. 
After 24 hours of PROM, the incidence of amnionitis 
rises to 10-30% (9)- Breese (21) showed that diminish¬ 
ing fetal size and increasing latent period are propor¬ 
tional to each other and showed that mortality also cor¬ 
relates with both diminishing fetal size and increased 
duration of the latent period. Hence, the premature 
fetus, who needs the extra time in utero to achieve 
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maturation, is the one most at risk for developing 
infection due to a longer latent period. 
In 1982 Mueller-Heubach et al (22) showed that 
there was only a slightly higher risk of infection when 
the time elapsed between rupture and delivery exceeded 
24 hours, and marked decrease in the incidence of in¬ 
fection was seen with advancing gestational age. The 
highest rate of infection in their series was less than 
15# and occured in pregnancies between 27 and 30 weeks - 
The authors showed that the length of the latent period 
was a far less important factor than gestational age 
for the risk of neonatal infection, which they defined 
as culture-proven septicemia or meningitis, or autop¬ 
sy-proven pneumonia. 
PROM Before and After 35 Weeks Gestational Age 
The decision between expeditious delivery and ex¬ 
pectant management of a patient with PROM involves 
evaluating the risk of infection versus potential im¬ 
provement in neonatal outcome from extended in utero 
time. The more advanced the gestation, the more mature 
the fetus will be and the less the risk of infection. 
Thus, in order to determine which fetuses to deli¬ 
ver without waiting, it is necessary to compare the 
risk of death in the neonatal period of uninfected 
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neonates at various gestational ages with the risk of 
neonatal death resulting from infection at those same 
gestational ages. In their study, Mueller-Heubach et 
al (22) found that until 35 weeks gestation, the risk 
of a non-infected infant dying from prematurity or 
other causes is greater than the risk of that infant 
dying from infection. At 35 weeks gestation and more, 
the risk of neonatal death caused by infection is slight¬ 
ly higher than the risk of death from other causes. 
Therefore, the authors suggest than in patients 
over 35 weeks gestation with PROM, delivery should be 
accomplished without delay. In addition, it has been 
shown that prolongation of the latent period over 24 
hours in the term gestation is associated with an in¬ 
crease not only of perinatal deaths but also of intra¬ 
partum fever and maternal endometritis (23). 
PROM and the Neonatal Respiratory Distress Syndrome 
There is no general agreement concerning the 
relationship between PROM and the neonatal respiratory 
distress syndrome (RDS). There is a large volume of 
literature supporting and disclaiming the hypothesis 
that rupture of the membranes of more than 12 to 16 
hours per se accelerates fetal lung maturation in the 
preterm pregnancy (24). (See Table 2). In a major 
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study, Jones et al (25) found no relationship between 
PROM and decreased RDS. The authors studied 16,458 
consecutive births in which there were 205 cases of PROM. 
PROM was defined as rupture of membranes occuring more 
than 24 hours before delivery, and RDS was defined, as 
respiratory distress in the neonate with tachypnea, in¬ 
tercostal retractions and grunting beginning within the 
first three hours of life and lasting for at least 24 
hours or until death. A control group of infants of 
similar gestational age without PROM was established. 
The study has been criticized (9) on the grounds that 
gestational age was established only by menstrual his¬ 
tory and by the failure to further evaluate the effect 
of respiratory failure in the infants involved. 
In 1978 Berkowitz et al (26) reviewed the records 
of 340 infants of 36 weeks gestational age or less ad¬ 
mitted to Yale's Newborn Special Care Unit born after 
PROM. Twins and infants of diabetic mothers were ex¬ 
cluded from the data analysis. The authors found that 
rupture of membranes over 16 hours duration was associat¬ 
ed with a statistically significant reduction in the in¬ 
cidence of RDS in infants of 31 weeks gestational age or 
more. The association between PROM in excess of 16 hours 
and survival, however, was only statistically significant 
for infants of 33 weeks gestational age or more. 
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In this study PROM was defined as rupture of membranes 
prior to the onset of labor. The diagnosis of RDS was 
made on radiologic, laboratory, and clinical manifesta¬ 
tions of the disease. Wender et al (27) reported a 
case of a twin born at 3^ weeks with intact membranes 
who developed RDS at birth while the other twin, who had 
had prolonged rupture of membranes, did not develop RDS. 
Mead (24) has noted several inconsistencies in the 
reports supporting the association between PROM and 
decreased RDS. He points to the fact that in 1972, 
Alden et al (28) showed an association between increased 
survival of infants weighing less than 1000 gm and PROM. 
Nevertheless, there was no decrease in the incidence of 
RDS in these infants when compared to a weight-matched 
control group without PROM. Miller et al (29) showed 
a decrease in RDS in infants weighing between 1000 and 
1500 gm with an increase in the duration of ruptured 
membranes. He found that the incidence of RDS was not 
altered by PROM when the birth weight was more than 1500 
gm. Moreover, as with Berkowitz's series, perinatal mor¬ 
tality remained unaltered with an increase in the dura¬ 
tion of PROM. Seidl (30) showed a significanly lower 
incidence of RDS in newborns of 33 "to 36 weeks gesta¬ 
tional age with PROM of only one hour duration or more 
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when compared to infants of similar gestational ages 
with PROM of less than one hour duration. Worthington 
(31) suggested that fetal lung maturation occurred be¬ 
fore membranes ruptured since he found that PROM was asso¬ 
ciated with a lower incidence of RDS regardless of the 
length of the latent period. 
Presently, the protective effect of PROM against 
RDS is not universally accepted, but the validity of this 
association must be considered as a potential significant 
variable in studies attempting to induce pulmonary matu¬ 
ration in cases of PROM. 
Management of PR OM 
The management of PROM in preterm pregnancies 
is a major controversy in modern perinatology. There 
is little controversy when PROM occurs after 35 weeks 
gestation, when most fetuses can be safely presumed to 
be mature, and delivery is indicated (23). 
In the preterm pregnancy complicated by PROM, the 
leading cause of neonatal morbidity and mortality is RDS. 
A large body of data from recent studies (32) focusing on 
infection-related ouctomes strongly suggests that although 
the incidences of perinatal death overall and perinatal 
death due to infection, neonatal sepsis, intrapartum 
fever and maternal endometritis are increased in patients 
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delivering before term compared to those delivering at 
term, the risks due solely to PROM are insignificant 
compared with the risk associated with preterm delivery 
per se (RDS, intraventricular hemorrhage, apnea and 
bradycardia, hyperbilirubinemia, etc.)* Thus prematu¬ 
rity, not infection, poses the greatest risk to the neo¬ 
nate in cases of PROM before term, and recent efforts have 
focused on prolonging pregnancy or preventing or amelio¬ 
rating RDS with the use of corticosteroids. 
When PROM occurs before 35 weeks gestation, a ma¬ 
nagement strategy must be selected. Advocates of conser¬ 
vative management argue that delaying delivery in patients 
with PROM, no signs of infection, and no documented fetal 
pulmonary maturity will result in significant pulmo¬ 
nary as well as general fetal maturation. As discussed 
above, several studies (9>22,23) of conservative manage¬ 
ment of PROM have shown that the risk of prematurity is 
greater than the risk of infection, and prematurity cau¬ 
ses a far greater number of neonatal deaths than infec¬ 
tion in neonates delivered after PROM. Unfortunately, 
in series reported to date, less than 10% of patients 
with PROM in a preterm pregnancy will have a latent pe¬ 
riod of one week or more (3^)* Even with the use of 
tocolytics, delay in delivery for six days or more is 
achieved in only 10.5-38.5% of patients(17)* Thus, 
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expectant management of preterm PROM does not appear 
to have adverse effects on the incidence of maternal or 
neonatal infection but is not very effective in achiev¬ 
ing significant extensions of intrauterine life. 
Aggressive management of preterm PROM generally 
implies the use of corticosteroids followed by delivery 
within 24 to 48 hours. In a landmark paper in 1972, 
Liggins and Howie (35) showed that a significant reduc¬ 
tion in RDS was achieved in newborns of women treated 
with betamethasone and in whom delivery is between 28 
and 32 weeks provided that the interval between treat¬ 
ment and delivery is more than one day but less than one 
week. No adverse effects on neonates or mothers were 
noted. Several series have since appeared and widely 
varying incidences of RDS after steroid therapy have 
been reported (17). In addition, a major concern with 
steroid therapy in pregnancies with PROM is the masking 
of maternal and fetal infection. Glucocorticoid therapy 
will produce leukocytosis for up to 48 hours after the 
last dose, thus eliminating this indicator of infection. 
However, Kuhn et al (36) found no significant differen¬ 
ces in rates of infectious morbidity for mothers and 
infants in steroid-treated and control groups. Mead 
(37) also found no differences in morbidity in newborns 
born to steroid-treated and control groups. 
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Usefulness of Amniocentesis in Patients with PROM 
It is obviously desirable to be able to predict 
which patients with PROM are destined to develop clinical 
chorioamnionitis so that appropriate steps can be taken 
to ensure early diagnosis and minimize morbidity. The 
classical clinical findings of chorioamnionitis may not 
be present in all cases. Fetal tachycardia, leukocyto¬ 
sis and tachycardia in the mother, fever, uterine tender¬ 
ness and purulent, foul-smelling discharge are late-ap¬ 
pearing signs indicating a well-established infection 
(32). Before attempting to prolong pregnancy in the 
preterm patient with PROM, an effort should be made to 
rule out occult intrauterine infection. In the absence 
of clinical signs of infection, Gram stain and culture of 
the amniotic fluid obtained transabdominally are the only 
reliable methods for diagnosing incipient chorioamnio¬ 
nitis (38,39)- Garite and Freeman (38) found that a 
positive Gram stain for bacteria on a smear of amniotic 
fluid obtained by amniocentesis was 81% sensitive and 78% 
specific in predicting clinical infection. Unfortu¬ 
nately, the study group was composed of only 91 preg¬ 
nancies and fluid was obtained in only 51^ of these. 
The authors updated their results in 1982(39) and found 
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that in afebrile patients, amniocenteses positive for 
bacteria on Gram stain and/or with subsequent positive 
culture correlated with subsequent development of ante¬ 
natal maternal fever. Fetal tachycardia, maternal leu¬ 
kocytosis, and uterine contractions were not predictive 
of intrauterine infection in afebrile patients. Hill 
(40) found good correlation between a positive culture 
and subsequent chorioamnionitis, but bacteria on the 
smear did not correlate well with the development of 
neonatal infection. Leukocytes on the amniotic fluid 
smear is generally thought not to be a significant cli¬ 
nical finding (39*40). 
In addition to bacterial studies, fluid obtained 
at amniocentesis can be used to test for fetal pulmona¬ 
ry maturity (41). The ratio of lecithin to sphingomy¬ 
elin (L/S ratio) and the presence of phosphatidyl gly¬ 
cerol (PG) in the amniotic fluid are the most commonly 
used measures of fetal pulmonary maturation. 
Amniocentesis is not an entirely harmless pro¬ 
cedure. Potential complications include fetal trauma, 
bleeding from injured cord or placental vessels, ini¬ 
tiation of labor or introduction of infection. These 
complications are unusual, however, and the finding of 
bacteria on Gram stain of amniotic fluid appears to 
be a rapid, practical and precise technique for iden- 
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tifying patients with early chorioamnionitis. 
Chorioamnionitis 
Infection of the amniotic sac, also referred to as 
amnionitis, chorioamnionitis, intraamniotic infection, 
amniotic infection or intrauterine infection is diagnosed 
clinical in 0.5-1% of all pregnancies but in 3-35% of 
those with rupture of membranes of more than 24 hours 
duration (42). In addition, over 50% of placentas of 
stillbirths show histological evidence of chorioamnio- 
nitis at autopsy (43). 
Infection of the fetal membranes most commonly 
results from ascentind infection from the cervicovaginal 
system (44). The histogenesis of chorioamnionitis al¬ 
ways shows the same pattern (10): The exudative reac¬ 
tion begins in the large chorionic vessels of the chorio¬ 
nic plate or within the umbilical cord vessels themselves. 
Initially there is margination of leukocytes within the 
vessels, followed by transmural migration of the cells. 
The leukophilic reaction occurs beneath the amniotic epi¬ 
thelium and the integrity of the amnion is generally pre¬ 
served, except for focal areas where necrosis of the cells 
and spread of infected material into the amniotic cavity 
may occur. As a consequence of the pathological events, 
infection of the fetus may ensue. Most commonly, fetal 
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infections results from ingestion or aspiration of in¬ 
fected amniotic fluid, but it can arise through hemato¬ 
genous spread via the infected fetal vessels of the cho¬ 
rionic plate or cord, resulting in primary fetal sep¬ 
ticemia. 
Once chorioamnionitis is diagnosed, most authors 
support the need for prompt delivery and initiation of 
antibiotic therapy. Gibbs et al (45) found no correla¬ 
tion between fetomaternal outcome and interval between 
diagnosis of chorioamnionitis and delivery, provided that 
delivery was accomplished within 24 hours of diagnosis. 
Several recent studies have employed prophylactic 
antibiotics in patients with PROM, but few did so in 
standardized fashion (17)* Habel et al (46) studied 
100 infants born after 24 or more hours of PROM where 
antiobiotics had been used prophylactically. They found 
that infections were few but fungal infections were in¬ 
creased compared to a control group with PROM but no 
antibiotics. The authors concluded that prophylactic 
antibiotics were not useful in PROM. In addition, use 
of antibiotics before delivery complicates management of 
the newborn, since neonatal blood cultures may be negative 
despite neonatal infection (9). Recent interest in the 
use of prophylactic antibiotics in PROM has been less 
than in the past. 
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Neonatal Infection After PROM 
Chorioamnionitis is a significant predisposing 
factor of early onset septic complications in the neo¬ 
nate such as pneumonia and meningitis. 
Septicemia develops quite readily in newborns 
either as a primary entity or as a sequela of infection 
during intrauterine life. Commonly, it is produced by 
enteric organisms characterized by their minimal virulence 
in the adult (44). Infection with organisms of higher 
virulence, such as the streptococcus, is becoming less 
common, and presently Group B streptococcus is the only 
streptococcus still important in the neonatal period. 
Staphylococcus is still important and can cause fulminant 
neonatal sepsis (47). 
Neonatal septicemia usually does not present cli¬ 
nically with the high fever, leukocytosis and prostration 
characteristic of infections in later life. There may be 
leukopenia, thrombocytopenia, or hypothermia (47). Many 
infants give a clinical impression of sepsis but only in 
a minority of these can the diagnosis be confirmed by 
blood culture (48). 
Garite and Freeman (38) found that duration of ma¬ 
ternal fever and chorioamnionitis are not statistically 
related to perinatal mortality. Siegel and MacCracken 
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found an incidence of culture-proven septicemia in only 
5^ of neonates born after chorioamnionitis had been diag¬ 
nosed in the mother. 
After the 36th week of pregnancy, healthy infants 
of healthy mothers born after PROM may be treated as 
uninfected neonates as their infection risk is minimal, 
according to Eisenberg and Krauss of Cornell (49). Be¬ 
fore this gestational age, the authors suggest that in¬ 
fants should receive a full septic workup, and antibio¬ 
tic therapy should be instituted until culture results 
are reported as negative. 
Management of PROM at Yale-New Haven Hospital 
At Yale-New Haven Hospital, patients who rupture 
their membranes prematurely are managed as follows: A 
sterile speculum examination of the cervix is performed 
on admission and the presence of ruptured membranes is 
confirmed by fluid crystallization (fern test), nitra- 
zine, and the presence of amniotic fluid pool in the 
vagina. If the patient is without clinical signs of in¬ 
fection and is over 36 weeks gestation with a negative 
glucose tolerance test, then she is induced is no spon¬ 
taneous labor ensues after 6 to 12 hours. 
In the clinically uninfected patient with PROM 
before 36 weeks gestation, every effort is made to ob- 
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tain amniotic fluid by amniocentesis after gestational 
age and fetal weight are estimated by ultrasound exa¬ 
mination. If amniocentesis is successful, fluid is sent 
for L/S ratio, PG, Gram stain and bacterial cultures. If 
the Gram stain is negative for bacteria, the patient is 
placed on bedrest and is followed closely with frequent 
determinations of vital signs, daily leukocyte and dif¬ 
ferential blood counts, and observation for any signs of 
labor. If the L/S or PG studies determine that there is 
fetal pulmonary immaturity, an expectant management plan 
is instituted with an attempt to prolong the pregnancy 
sufficiently for fetal maturity to ensue. Beta-mimetic 
agents and magnesium sulfate are used as tocolytics if 
the patient shows signs of labor but no clinical signs 
of infection. Repeat amniocenteses are performed at 
weekly intervals in the absence of labor to ensure that 
the amniotic fluid is not colonized and to follow fetal 
pulmonary maturity parameters. Amniocentesis is also 
repeated if the patient shows signs of labor or possible 
infection. Once fetal pulmonary maturity is documented, 
tocolytics are discontinued if they were being used and 
spontaneous labor is awaited. If the patient is near 
term, she may be induced. 
In the patient under 36 weeks gestation in whom 
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amniocentesis is impossible and who is clinically un¬ 
infected, expectant management is instituted until signs 
of infection develop. Tocolytics are sometimes used but 
with great trepidation since contractions may be a sign 
of infection. If increased gestational age is achieved 
and fetal lung maturation can be safely inferred to have 
occurred, the patient is allowed to go into labor or may 
be induced. 
Patients are induced if the Gram stain of the amnio- 
tic fluid is positive for bacteria or if the patient de¬ 
velops signs of chorioamnionitis. If the patient is 
being given beta-mimetic agents for tocolysis, maternal 
and fetal tachycardia are not used as markers of chorio¬ 
amnionitis because of the chronotropic effects of these 
agents on the maternal and fetal hearts. 
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MATERIALS AND METHODS 
The data were obtained by reviewing the charts of 
patients admitted to the Maternal Special Care Unit at 
Yale-New Haven Hospital with the admitting diagnosis of 
PROM or who had the discharge diagnoses of PROM and Pre¬ 
mature Birth Living Child during the period of January 
1, 1981 to July 31, 1983- Patients were excluded from 
the study if they were over 36 weeks gestation at the 
time of PROM (n = 42), a twin gestation was present 
(n = 8), the patient delivered at another hospital (n = 
4), the patient received corticosteroids (n = 2) or if 
the patient was admitted in active labor (n = 11). A 
total of 147 maternal charts and 140 neonatal charts 
were included in the study. 5 neonatal charts were lost 
of unavailable for review. There were 2 stillbirths. 
The study group included clinic and private patients 
as well as transfers from one of the referring hospitals. 
Rupture of membranes was documented by fluid crystalli¬ 
zation (fern test). No digital examinations were performed 
although some patients had been examined before admission 
to Yale-New Haven Hospital. Patients with questionable 
PROM who had negative fern tests were not included in 
the study. Patients were managed according to the Yale 
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protocol described above. Amniocentesis was performed 
under direct ultrasound guidance. 
The data were collected and coded as shown in 
Appendix 2. 
STATISTICAL METHODS 
All the data were transferrred to IBM Standard 
Tape and analyzed by use of an IBM computer. Analysis 
2 
of data was performed using x and 2-tailed Student t tests. 
RESULTS 
(All Tables and Figures are in Appendix 1) 
There were 147 patients with preterm PROM in this 
study. 84 (57%) were white, 50 (34$) were black, 8 
(5-3$) were of Hispanic origin, and 5 (3*6$) were of 
other origin. 66 (45$) were nulliparas, and 80 (55$) 
had had one or more prior deliveries. 100 (71$) were 
transferred from one of the referring hospitals, 25 
(18$) were local clinic patients, and 15 (11$) were local 
private patients. The small percentage of private local 
patiens might be explained by the fact that some private 
attending physicians will follow their PROM patients 
at home with bedrest and close attention to clinical 
signs of infection. Ages of the patients in the study 
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group ranged from 16 to 40 years. Amniocentesis was 
attempted in 87 patients (59-2$) and was successful in 
77 (52.4%). B8% of amniocenteces were successful in 
obtaining amniotic fluid. 17 patients had two or more 
amniocenteses. The gestational ages at the time of PROM 
of the patients in the study group are shown in Figure 1. 
Several maternal parameters were analyzed for cor¬ 
relation with a positive amniotic fluid culture to de¬ 
termine if any one factor could be predictive of a posi¬ 
tive culture. Since uterine tenderness in not an objec¬ 
tive or quantitative factor, it was not included in the 
analysis. The presence or absence of foul-smelling 
fluid on admission was rarely reconred on patient charts 
and was not included. Table 3 shows that admission ma¬ 
ternal leukocyte counts (WBC count), neutrophil and band 
counts, uterine contractions, absolute neutrophil count, 
heart rate and temperature were not predicitve of po¬ 
sitive amniotic fluid culture. Similarly, admission 
fetal heart rate was not predictive of a positive cul¬ 
ture. Since a small percentage of patients had an in¬ 
terval of more than 24 hours between admission and am¬ 
niocentesis, several clinical parameters at the time 
of the amniocentesis were analyzed. Table 4 shows that 
the following paremeters at the time of amniocentesis 
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were not predictive of a positive amniotic fluid cul¬ 
ture: maternal age, gestational age, gravidity, parity, 
temperature, WBC count, neutrophil count, band count, 
absolute neutrophil count and uterine contractions. 
That is, these factors were no different in those pa¬ 
tients with a negative amniotic fluid culture from 
those in patients with a positive culture. 
As has been reported previously, (38*39) amniotic 
fluid obtained at amniocentesis can be Gram stained to 
look for the presence of bacteria. Of the 77 successful 
amniocenteses, the results of 76 Gram stains and 75 
cultures were examined. Of the 75 cultures, 24 (32$) 
were positive. Two of the positive culture were consid¬ 
ered contaminants because of the organisms involved 
(Staphylococcus coagulase - ) and low colony counts. 
Neither of these had positive Gram stains. The orga¬ 
nisms cultured are shown on Table 5* Table 6 shows 
that Gram stain of the amniotic fluid was 61.9^ sen¬ 
sitive and 91-8$ specific in predicting which patients 
were destined to have a positive amniotic fluid culture. 
The results of one Gram stain and one culture were not 
available for review. In one case not enough fluid 
was obtained for cultures to be obtained. 
To determine whether a positive culture correlated 
with increased maternal morbidity, maternal clinical 
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parameters were followed from the time of amniocentesis 
to the time of delivery. A positive culture did not 
correlate with elevated antepartum temperature, ele¬ 
vated antepartum WBC count, increased neutrophil or 
band count or intrapartum temperature. A positive 
culture did, however, correlate with an increased ad¬ 
ministration of antibiotics antepartum and an increased 
rate of clinical diagnosis of amnionitis. Patients 
who had positive cultures underwent Cesarean sections 
more than those with negative cultures (36.4% versus 
22.4%) but the difference was not statistically signi¬ 
ficant. Table 7 shows the correlation between culture 
result and subsequent maternal clinical course. One 
patient suffered a complication of amniocentesis 
(possible puncture of fetal vessel) without detrimen¬ 
tal consequences to either mother or infant. 
There were 145 live births and 2 stillbirths. 
4 infant charts were unavailable for review, but the 
neonatal outcome was known for all births. 9 infants 
(6.6%) had positive blood cultures; 2 of them from 
mothers with positive amniotic fluid cultures, 2 from 
mothers with negative cultures, and 5 from mothers 
without amniocenteses. 2 infants with negative blood 
cultures had radiographically-proven pneumonia; one 
from a mother with a positive amniotic fluid culture 
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and one from a mother with no amniocentesis. 2 infant 
blood cultures were considered contaminants by the at¬ 
tending pediatricians. Both stillbirths were to mothers 
with positive amniotic fluid cultures. Statistically 
significant differences in gestational age at delivery 
and birth weight between infants of mothers with ne¬ 
gative cultures and mothers with positive cultures are 
shown in Table 8. 
There were 9 neonatal deaths, which with the two 
stillbirths gives a perinatal mortality rate of 7-5%* 
5 deaths (3.4%) were attributable to prematurity, 2 to 
infection (1.4%) and 2 (1.4%) to multiple congenital 
abnormalities. Both stillbirths were believed to have 
been caused by amnionitis, hence the infection-related 
perinatal mortality rate was 2.7%. 
Figures 2 and 3 show the Apgar scores of infants 
from mothers with positive and negative cultures at 
one and five minutes respectively. Table 9 shows 
statistically significant differences between both groups 
of infants. The percentage of infants with Apgar score 
of five or less at one minute is significantly higher 
in the group born to mothers with positive cultures. 
Similarly, significantly more infants born to mothers 
with positive cultures had Apgar scores at five minutes 
of seven or less. 
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Tocolytics were used in 76 patients. In 46.7% 
of these, delivery occurred one day or less after ini¬ 
tiation of tocolytic agents. 78-3% of patients given 
tocolytics delivered less than 7 days after tocolytics 
were started, but delivery was delayed for one week 
or more in 22.7% of patients. These results are con¬ 
sistent with those recently reported by others (50,51). 
(See Figure 4). Since tocolytics were not started im¬ 
mediately after membrane rupture in most patients, the 
interval between PROM and delivery in some patients is 
greater than the interval between initiation of toco¬ 
lytics and delivery. 
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DISCUSSION 
Despite dramatic advances in the field of peri¬ 
natology during the last decade, there has been no 
clear-cut progress in the development of an appro¬ 
priate management strategy for preterm PROM. Clini¬ 
cians are now equipped with several new resources : 
amniocentesis, corticosteroids, tocolysis, neonatal 
intensive care units. 
The preterm patient with prematurely ruptured 
membranes is particularly prone to developing chorioam- 
nionitis (9»21,22,42 ) . Unfortunately, clinical signs 
develop only after the infection is usually well-esta¬ 
blished. Several studies (38,39.44-46) have shown that 
chorioamnionitis is associated with significantly in¬ 
creased neonatal morbidity and mortality. Thus, ex¬ 
peditious delivery seems indicated in cases where cho¬ 
rioamnionitis has been diagnosed (35»42,44-46). It is 
desirable to be able to predict which patients with 
PROM but without clinical signs of infection are des¬ 
tined to develop clinical chorioamnionitis, since efforts 
at prolonging pregnancy in the preterm PROM patient must 
rule out occult intrauterine infection. 
In the patient with PROM, examination of amniotic 
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fluid obtained by amniocentesis allows the clinician 
to detect pulmonary maturity and infection. Unfor¬ 
tunately, in cases of PROM amniocentesis is successful 
only in about half of the patients (38-40). In the 
other half, amniocentesis cannot be performed or no 
fluid can be obtained. 
The data in the present study agrees with these 
observations, since fluid was obtained in only 52.4^ 
of the patients in the study group. In those patients 
in which amniocentesis was successful, though, admis¬ 
sion clinical parameters or more importantly, parame¬ 
ters at the time of the amniocentesis were almost iden¬ 
tical in women with positive amniotic fluid cultures to 
those in women with negative cultures. That is, there 
was no way to predict clinically what patients were des¬ 
tined to have a positive amniotic fluid culture. A 
positive culture was associated with a significantly 
worse neonatal outcome than a negative culture. Po¬ 
sitive cultures, however, did not seem to be associated 
with increased maternal morbidity. 
Statistically significant conclusions were diffi¬ 
cult to draw in some instances because of varying ges¬ 
tational ages at the time of delivery between patients 
with negative and positive cultures and by difficulties 
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in diagnosing and grading RDS. There were signifi¬ 
cantly more cases of moderate and severe RDS in in¬ 
fants from mothers with positive cultures, but the 
mean gestational age at delivery and mean birth weight 
of infants in this group was significantly lower than 
in the group with negative cultures. Both gestational 
age and birth weight are significant variables in the 
development of RDS. 
A larger percentage of patients with positive 
cultures underwent cesarean sections than those with 
negative cultures, but this difference could have been 
due to the earlier gestational ages of the group with 
positive cultures and its correspondingly greater in¬ 
cidence of breech and transverse lies. 
Although amniocentesis is not an entirely safe 
procedure, the complication rate in our study was very 
low (1.1%) and no major complications were seen. Un¬ 
fortunately, results of amniotic fluid cultures take 
48 hours or more to be reported. Gram stain of the am¬ 
niotic fluid provied a rapid way of detecting the pre¬ 
sence of amniotic fluid colonization. Results from this 
study show that Gram stain of the fluid was 62% sen¬ 
sitive and 92% specific in predicting a positive cul¬ 
ture. Other authors (38>39) have reported slightly 
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higher sensitivities and slightly lower specificities. 
The accuracy of the Gram stain is crucial in ma¬ 
naging the patient with PROM. A false-positive Gram 
stain may lead to an inappropriately early delivery re¬ 
sulting in potentially avoidable complications of pre¬ 
maturity. A false-negative Gram stain may lead to ha¬ 
zardous prolongation of intrauterine life in the pre¬ 
sence of colonization, although it is unclear whether 
there is any real advantage in delivery before infec¬ 
tion is clinically evident (17). 
One of the criticisms of conservative management 
of preterm PROM is that although infection is not a 
serious problem, delivery cannot be delayed sufficient¬ 
ly in most cases to allow for significant fetal matu¬ 
ration (17,3^). this study nearly half the patients 
delivered within a day of initiation of tocolytics, but 
in almost a quarter of them delivery was delayed for 
more than one week. At present it is not possible to 
predict which patients will respond favorably to toco¬ 
lytic therapy. 
In summary, amniocentesis should be included in 
the evaluation of the preterm patient with PROM in whom 
a delay in delivery is being considered in the manage¬ 
ment plan. Unresolved problems in the conservative 
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management of preterm PROM include the large percen¬ 
tage of patients in which amniocentesis is not feasible 
or is unsuccessful, inability to delay delivery in some 
cases even in the absence of infection, and inaccuracy 
of the Gram stain. However, Gram stain of the amniotic 
fluid obtained by amniocentesis is at present the only 
way to obtain rapid information about the presence or 
absence of amniotic fluid colonization in cases of PROM. 
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APPENDIX 1 
TABLE 1: INCIDENCE OF PROM 
Definition 
Author # Pregnancies # PROM % PROM of PROM 
Clark Sc 
Anderson 
(1) 
33,022 1,009 2.1 + + + 
Lanier 
et al 
(2) 
7,637 473 6.2 ROM outside 
the hospital 
Breese 
(3) 
44,723 2,862 6.4 
ROM 1 hr be¬ 
fore onset 
of labor 
Russel & 
Anderson 
(4) 
31,865 2,645 8.3 
ROM before 
onset of 
labor 
Burchell 
(5) 
18,138 1,795 9-9 
ROM 1 hr be¬ 
fore onset 
of labor 
Gunn et al 
(6) 
17,562 1,884 10.7 ROM before 
onset of 
labor 
Lebherz 
et al 
(7) 
25,427 2,923 11.5 
ROM 1 hr be¬ 
fore onset 
of labor 
Rovinsky & 
Shapiro 
(8) 
30,336 3,793 12.5 
ROM 1 hr be¬ 
fore onset 
of labor 
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TABLE 2: RELATIONSHIP BETWEEN PROM AND DECREASED RDS (24) 
A. Studies showing no association 
Liggins: Modern Perinatal Medicine, 1974 
Jones: NEJM 292:1253, 1975 
Dimmick: Obstet Gynecol 47:56, 1976 
Christensen: Obstet Gynecol 48:670, 1976 
Dluholucky: Arch Dis Child 51:^20, 1976 
Bada: Pediatr Res 10:420, 1976 
Lee: Pediatr Res 10:463, 1976 
Barrada: Am J Obstet Gynecoi 129:25, 1977 
Quirk: Am J Obstet Gynecol 134:768, 1979 
Taeusch: Pediatrics 63:64, 1979 
Schreiber: Am J Obstet Gynecol 136:92, 1980 
B. Studies suggesting a beneficial effect 
Alden: Pediatrics 50:40, 1972 
Yoon: Pediatrics 52:161, 1973 
Chiswick: Lancet 1:100, 1973 
Gluck: Am J Obstet Gynecol 115:539, 1973 
Richardson: Am J Obstet Gynecol 118:115, 1974 
Bauer: Pediatrics 53:7, 1974 
Cohen: J Pediatr 98:1007, 1977 
Berkowitz: Am J Obstet Gynecol 131:503, 1978 
Sell: Obstet Gynecol 49:167, 1977 
Thibealt: Am J Obstet Gynecol 129:43, 1977 
Seidl: Eur J Ob Gyn & Rep Biol 7:257, 1977 
Worthington: Obstet Gynecol 49:275, 1977 
Miller: Am J Obstet Gynecol 132:1, 1978 
Obladen: Am J Obstet Gynecol 135:1079, 1979 
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TABLE 2s ADMISSION DATA ON PATIENTS WITH 
SUCCESSFUL AMNIOCENTESES-1- * 
PARAMETER (-) CULTURE (+) CULTURE 
Mean temperature 98.8 
Mean # contractions 
in 10 min 1.04 
Mean WBC count 
(xlOOO) 
11.1 
Mean neutrophil 
count (f) 72.8 
Mean band count 
{$) 
5-35 
Mean absolute neu¬ 
trophil count 
(xlOOO) 
8.84 
Mean fetal heart 
rate 
146 
Mean maternal 
heart rate 
- 0.81 98.5 - 0.62 
±1.43 1.02 ± 1.41 
± 3.04 10.7 ± 3.31 
±8.18 71.6+8.20 
± 4.70 7.23 ± 6.49 
t 305 8.57 ± 3.07 
17.3 144 ± 11.6 
t 13.6 91.9 ± 14.2 
+Differences in parameters between groups are all 
statistically not significant. 
* . + 
All means are given as N I S.D. 
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TABLE 4: DATA AT TIME OF AMNIOCENTESIS OF PATIENTS 
WITH POSITIVE AND NEGATIVE AMNIOTIC FLUID 
CULTURES* 
PARAMETER (-) CULTURE (+) CULTURE 
Mean maternal age 26.4 1 5.49 27.4 ± 4.98 
Mean gestational 
age 31.2 ± 2.71 
30.0 4 3.43 
°/o primigravidas 25.8 13.8 
% nulliparas 51.9 24.5 
Mean temperature 98.5 ± 0.58 98.8 4 0.76 
Mean WBC count 
(xlOOO) 11.0 ± 3.50 10.8 ± 3.8I 
Mean neutrophil 
count (xlOOO) 71.3 ± 9.67 73.5 7 11.3 
Mean band count 
(xlOOO) 8.3O ± 6.85 6.45 + 4.85 
Absolute neutrophil 
count (xlOOO) 8.87 - 3.36 8.81 t 3.65 
% having contrac¬ 
tions 43.0 36.0 
^Differences in parameters are not statistically 
significant. 
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TABLE 5: ORGANISMS CULTURED FROM AMNIOTIC FLUID* 
Streptococcus viridans 4 
v 
Escherichia coli 4 
Diphtheroid sp 4 
Peptostreptococcus 3 
Enterococcus 3 
Haemophilus vaginalis 3 
Fusobacterium nucleatum 2 
Bacteroides fragilis 2 
Group D Streptococcus 2 
Haemophilus influenzae 2 
Group B streptococcus 1 
Neisseria gonorrheae 1 
Proteus mirabilis 1 
Candida albicans 1 
* 
Some cultures grew multiple organisms 
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TABLE 6: ACCURACY OF GRAM STAIN OF AMNIOTIC FLUID 
IN PREDICTING A POSITIVE AMNIOTIC FLUID 
CULTURE* 
TRUE POSITIVES 13 
FALSE NEGATIVES 8 
SENSITIVITY 61.9$ 
TRUE NEGATIVES 45 
FALSE POSITIVES 4 
SPECIFICITY 91,8$ 
^Results of one Gram stain were unavailable 
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TABLE 7: CULTURE RESULT AND SUBSEQUENT MATERNAL COURSE* 
(-) culture (+) culture 
Highest antepartum 
temperature 99.2 + 0.77 99*4 + 0.88 N.S. 
Highest antepartum 
WBC count (xlOOO) 13-6 + 4.26 12.3 +4.08 N.S . 
Highest antepartum 
neutrophils {%) 70.9 1 13.3 ^
0
 
t—1
 
0
 
1 +
 i—1
 
0
 
0
 
N.S . 
Highest intrapartum 
temperature 99.6+1.08 99.6 + 1.11 N.S . 
Cesarean section 
rate 
22 .4fc 36.4$ N.S. 
Clinical diagnosis 
of amnionitis 41.1$ 68.5$ p <0.05 
Days between ROM 
and delivery 11.6 + 18.1 3.64 + 5.30 p <0.05 
Gestational age at 
time of delivery 
(weeks) 
32.8 + 2.68 30.5 + 3.55 p < 0.01 
Antibiotics admi¬ 
nistered antepartum 14.3$ 41.0$ p < 0.05 
* AIL figures (except $'s) are means. 
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TABLE 8: MEAN GESTATIONAL AGE AT DELIVERY AND MEAN 
BIRTH WEIGHT OF INFANTS OF PATIENTS WITH 
POSITIVE AND NEGATIVE AMNIOTIC FLUID 
CULTURES* 
(-) culture (+) culture 
Mean gestational 
age at delivery 30.5 ± 3-55 32.8 + 2.68 
(weeks) 
Mean "birth weight 
(grams) 1885 ± 524.4 1512 + 620.0 
*p <0.05 
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TABLE 9: STATISTICALLY SIGNIFICANT DIFFERENCES IN 
INFANTS BORN TO MOTHERS WITH POSITIVE AND 
WITH NEGATIVE AMNIOTIC FLUID CULTURES 
(-) culture (+) culture 
Apgar1 <5 
or stillbirth 
w 
Apgar1 >5 73-5 
65.2 
p < 0.01 
34.8 
Apgar ^ <7 or 
V. 21.2 
stillbirth 
(tf) 
Apgar 5±7 78.7 
60.8 
39-2 
P <0.05 
Antibiotics 
administered 70.2 100.0 p<0.01 
to infant \fo) 
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FIGURE 1: GESTATIONAL AGE AT THE TIME OF RUPTURE OF 
MEMBRANES 
Gestational age at the time of 
rupture (weeks) 
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FIGURE 2: APGAR SCORE AT ONE MINUTE BY AMNIOTIC 
FLUID CULTURE RESULT 
□= negative culture 
positive culture 
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FIGURE 3: APGAR SCORE AT FIVE MINUTES BY 
AMNIOTIC FLUID CULTURE RESULT 
= negative culture positive culture 
Apgar^ score 
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FIGURE 4: INTERVAL BETWEEN INITIATION OF TOCOLITICS 
AND DELIVERY 
Days between initiation of tocolytics and 
delivery 
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APPENDIX 2 
STUDY ID 
NAME 
UNIT NUMBER 
AGE 
RACE 
GRAVIDITY 
PARITY 
1 4 
5 18 
19 25 
26 27 
b-White; 2-Black; 3-Hispanic; 
28 4-Other; 5-Not recorded 
29 1-Primigravida; 2-Multigravida; 3-No available 
1-Nullipara; 2-Multipara; 3-Not available 
30 
BEST GA AT TIME OF PROM 
3l 33 
DATE OF PROM 
34 
/ / 
39 
TIME OF PROM 
40 43 
PELVIC EXAMINATION 1-Yes; 2-No; 3-Not recorded 
PRIOR TO LABOR 44 
PATIENT CLASSIFICATION 
45 
1-Transfer; 2-Clinic-local; 
3-Private-local 
ADMISSION TO Y-NHH 
Temp on labor floor admission 
# contractions in 10 minutes 
Foul discharge: 1-Yes; 2-No; 
3-Not recorded 
Fetal heart rate on admission 
Maternal pulse on admission 
B-2 Agents administered prior to 1-Yes 
pulse and FHR recording 
Vaginal culture for group B strep 
1. Negative 2. Positive 
3. Not dene 
W B C 
Hematocrit 
Polys 
Bands 
60 62 
63 ~ 65 
66 67 
68 69 
2-No 
-48- 
46 47 48 49 
50 
51 
52 53 54 
55 ~ 57 
58 
59 
Card # _1 
72 

STUDY ID 
1 4 
LYMPHOCYTES 
5 6 
MONO _ 
7 8 
BASO 
9 10 
EOS 
11 12 
Was U/S done 1-Yes; 2-No 
3-Not Stated 13 
Date / / 
14 19 
E F W 
20 
grams 
23 ” 
PLACENTA 1-Anterior; 2-Posterior 
3-Not Stated 24 
Gestational age by dates • 
25 ~ 27 
Gestational age by clinical ex 
(IMP + size + quickening) 
• 
28 30 
Gestational age by early u/S 
(Prior to 28 weeks) 3l ~ 33 
Gestational age by U/S at PROM • 
34 ~ 36 
AMNOCENTESIS # 1 
Armiocentesis 1-Performed; 
2- Not attempted 
3- Not Stated 
37 
Fluid Obtained 1-Yes; 2-No 
38 
Date of Tap (If fluid obtained / / 
39 44 
Temp at time of tap • 
45 48 
WBC at time of tap • 
49 5l 
Segs 
52 53 
Bands 
Was the patient contracting 1-Yes 
2-No 
54 55 
56 
If Amniocentesis was not performed 
the reason was 1-Considered unsafe 57 
2-Other 
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Armiotic fluid 
58 
: 1-Clear 
2- Bloody 
3- Meconium 
4- Not Stated 
5- No fluid 
Canplication of amniocentesis 1-Yes 
2-No 59 
L/S Ratio 
Bacteria gram stain 
• 
60 61 
1- GPC _ 
2- GNR 62 
3- GNC 
4- GPR 
5- Other combinations 
6- No bacteria 
7- Nj<5^ 
WBC gram stain 1-Absent 
2- Present-few 
3- Moderate 
4- Many 
5- Not Stated 
Culture 1-Negative 
2- Positive 
3- Not Stated 
4- Not Obtained 
Did the patient have more 1-Yes 
than one amniocentesis 2-No 
AMNOCBsTTESIS # 2 
INDICATION 
1- Labor 
2- Routine 66 
3- Other 
# Days between first and 
second armiocentesis 67 
Fluid Obtained 1-Yes; 2-No 
68 
63 
64 
65 
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STUDY ID # 
Date of Tap (If fluid obtained 
Temp at time of tap 
WBC at time of tap 
Segs 
Bands 
Was the patient contracting 1-Yes 
2-No 
CARD # 2 
72 
1 3 
_/_/_ 
4 9 
To 13 
14 16 
17 18 
19 20 
21 
Armiotic fluid: 1-Clear 
2- Bloody 22 
3- Meconium 
4- Not Stated 
5- No fluid 
Complication of amniocentesis 1-Yes 
2-No 23 
L/S Ratio 
Bacteria gram stain 
» 
24 25 
1- GPC 
2- GNR 26 
3- GNC 
4- GPR 
5- Other combinations 
6- No bacteria 
WBC gram stain 1- Absent 
2- Present-few 
3- Moderate 
4- Many 
5- Not Stated 
27 
Culture 1- Negative 
2- Positive 28 
3- Not Stated 
4- Not Obtained 
Did the patient have more 1-Yes 
than two amniocentesis 2-No 29 
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AMNIOCENTESIS #3 
INDICATION 
1- Labor _ 
2- Routine 30 
3- Other 
# Days between second and 
third amniocentesis 31 
Fluid Obtained 1-Yes; 2-No 
Date of Tap (If fluid obtained 
Temp at time of tap 
WBC at time of tap 
Segs 
Bands 
Was the patient contracting 1-Yes 
2-No 
/ / 
32 
33 
39 42 
43 45 
46 47 
48 49 
50 
38 
Armiotic fluid: 1-Clear 
2- Bloody 
3- Meconium 
4- Not Stated 
5- No fluid 
Complication of amniocentesis 1-Yes 
2-No 
51 
52 
L/S Ratio 
Bacteria gram stain 
• 
53 54 
1- GPC 
2- (3srR 55 
3- GNC 
4- GPR 
5- Other combinations 
6- No bacteria 
WBC gram stain 1- Absent 
2- Present-fe*/ 56 
3- Moderate 
4- Many 
5- Not Stated 
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Culture 1- Negative 
2- Positive 57 
3- Not Stated 
4- Not Obtained 
INDICATION FOR DELIVERY 
58 
1- Labor unresponsive to tocolytes 
2- Aimionitis 
3- Mature L/S ratio 
4- Fetal distress 
5- Bacteria in gram stain _ 
6- Labor, no tocolytics _ 
7- Other 
LABOR 
59 
1- Spontaneou s 
2- Induced 
3- No labor 
If 2 or 3 
Delivery Date 
Type of Delivery 
1- Vaginal sponatenous 
2- C/Section 
3- Forceps 
4- Other 
Weight 
Tocolytics used 
1- MgSO 
2- Beta-Mimetics 
3- None 
STUDY ID # 
Apgar 1 minute 
Apgar 5 minutes 
_/_/_ 
60 65 
66 
67 70 
7l 
CARD # _3 
72 
T 3 
4 ~5 
6 ~7 
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Baby Unit # 
8 14 
Antepartum administration 
of antibiotics 15 
1- Yes 
2- No 
3- Other Indications 
Interval between PROM - last successful Tap_days 
16 17 
Interval between PROM - Delivery days 
18 20 
Clinical diagnosis of amnicnitis 
1-Yes; 2-No 21 
Highest antepartum temp • 
22 25 
Highest EHT (if no tocolytis) 
26 28 
Highest antepartum WBC • 
29 31 
Polys 
32 33 
Bands 
34 35 
Date / / 
36 41 
Highest intrapartum tanp • 
42 45 
Interval between PROM and days 
clinical diagnosis of amnicnitis 46 47 
Interval between PROM and days 
initiation of tocolytic agents 48 49 
Interval between initiation of days 
tocolytic - delivery 50 51 
Post-parturn Maternal infection 
1-None 2-Endometritis 3-LTTI 52 
4-Wound infection 5-Pneumonia 6-Other 
Highest post-partum temperature 
53 56 
Were antibiotics used post-partum 
1-Yes; 2-No 57 
Indication 
-54- 

58 
Blood Cultures (Maternal) 
1- Negative 
2- Positive 
3- Not done 
BABY 
Baby sex 
1- Male 
2- Female 
3- Not available 
Gestational age by physical exam 
IUGR: 1-Yes; 2-No; 3-Unknown 
Sepsis: 1-Yes; 2-No; 3-Unknown 
Foul smelling newborn 
1-Yes; 2-No; 3-Unknown 
Blood Cultures 
1- Negative 
2- Positive _ 
3- Not Done 
CSF Culture 
1- Negative 
2- Positive _ 
3- Not done 
Antibiotics administered to the baby 
1-Yes; 2-No; 3-Unknown 
RDvS 
1-No; 2-MiId; 3-Moderate; 
4- Severe; 5-Unkncwn 
Mechanic ventilation 
1-No; 2-CPAP only; 3-IMV; 4-Unknown 
59 
60 ~ 62 
63 
64 
65 
66 
67 
68 
69 
70 
CARD # 
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' 9 
STUDY # 
1 3 
Maximum FI02 
Nurrber of days in mechanic ventilation 
Intracranial henmorhage 
1-Yes; 2-No; 3-Not evaluated; 4-Unknown 
4 5 
6 ~1 
8 
Grade 
Necrotizing entercolytis 
1-Yes, 2-No; 3-Unkncwn 
Other Baby Complications 
1-Yes; 2-No; 3-Unkncv/n 
NICU days of hospitalization 
Neonatal deaths 
1-Yes; 2;-No; 3-Unknown 
Cause of neonatal death 
1-Prematurity; 2-Infection; 3-Other 
Direct cause of death 
9 
10 " 
II~I3 
14 
15 
CARD # 
-56- 
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